These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19169857)

  • 1. RNA interference inhibits yellow fever virus replication in vitro and in vivo.
    Pacca CC; Severino AA; Mondini A; Rahal P; D'avila SG; Cordeiro JA; Nogueira MC; Bronzoni RV; Nogueira ML
    Virus Genes; 2009 Apr; 38(2):224-31. PubMed ID: 19169857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
    Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
    Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure.
    Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR
    Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
    de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
    De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
    Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX.
    Assunção-Miranda I; Cruz-Oliveira C; Neris RL; Figueiredo CM; Pereira LP; Rodrigues D; Araujo DF; Da Poian AT; Bozza MT
    J Appl Microbiol; 2016 Mar; 120(3):790-804. PubMed ID: 26759117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.
    Zandi K; Amblard F; Amichai S; Bassit L; Tao S; Jiang Y; Zhou L; Ollinger Russell O; Mengshetti S; Schinazi RF
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
    Saito K; Shimasaki K; Fukasawa M; Suzuki R; Okemoto-Nakamura Y; Katoh K; Takasaki T; Hanada K
    Virus Res; 2022 Dec; 322():198935. PubMed ID: 36152929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
    Albarnaz JD; De Oliveira LC; Torres AA; Palhares RM; Casteluber MC; Rodrigues CM; Cardozo PL; De Souza AM; Pacca CC; Ferreira PC; Kroon EG; Nogueira ML; Bonjardim CA
    Antiviral Res; 2014 Nov; 111():82-92. PubMed ID: 25241249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
    Mastrangelo E; Pezzullo M; De Burghgraeve T; Kaptein S; Pastorino B; Dallmeier K; de Lamballerie X; Neyts J; Hanson AM; Frick DN; Bolognesi M; Milani M
    J Antimicrob Chemother; 2012 Aug; 67(8):1884-94. PubMed ID: 22535622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5.
    Ren H; Wang J; Tang H; Qian X; Xia B; Luo Z; Xu Z; Qi Z; Zhao P
    Antiviral Res; 2023 Nov; 219():105737. PubMed ID: 37879570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response.
    Gao Z; Zhang X; Zhang L; Wu S; Ma J; Wang F; Zhou Y; Dai X; Bullitt E; Du Y; Guo JT; Chang J
    PLoS Pathog; 2022 Jan; 18(1):e1010271. PubMed ID: 35061864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.
    Julander JG; Jha AK; Choi JA; Jung KH; Smee DF; Morrey JD; Chu CK
    Antiviral Res; 2010 Jun; 86(3):261-7. PubMed ID: 20227442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.
    Miorin L; Laurent-Rolle M; Pisanelli G; Co PH; Albrecht RA; García-Sastre A; Morrison J
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model.
    Lin K; Good SS; Julander JG; Weight AE; Moussa A; Sommadossi JP
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009937. PubMed ID: 35073319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The eukaryotic translation initiation factor 3 subunit L protein interacts with Flavivirus NS5 and may modulate yellow fever virus replication.
    Morais ATs; Terzian AC; Duarte DV; Bronzoni RV; Madrid MC; Gavioli AF; Gil LH; Oliveira AG; Zanelli CF; Valentini SR; Rahal P; Nogueira ML
    Virol J; 2013 Jun; 10():205. PubMed ID: 23800076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain).
    Ono L; Wollinger W; Rocco IM; Coimbra TL; Gorin PA; Sierakowski MR
    Antiviral Res; 2003 Nov; 60(3):201-8. PubMed ID: 14638396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.
    Qian X; Wu B; Tang H; Luo Z; Xu Z; Ouyang S; Li X; Xie J; Yi Z; Leng Q; Liu Y; Qi Z; Zhao P
    Emerg Microbes Infect; 2022 Dec; 11(1):873-884. PubMed ID: 35249454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of the host protein DNAJC14 as a broadly active flavivirus replication modulator.
    Yi Z; Sperzel L; Nürnberger C; Bredenbeek PJ; Lubick KJ; Best SM; Stoyanov CT; Law LM; Yuan Z; Rice CM; MacDonald MR
    PLoS Pathog; 2011 Jan; 7(1):e1001255. PubMed ID: 21249176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial inhibition of yellow fever virus replication in vitro with different phosphorothioate oligodeoxyribonucleotides.
    Tolou H; Puggelli H; Tock F; Durand JP
    Acta Virol; 1996 Apr; 40(2):73-9. PubMed ID: 8886115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.